Certified by Founder Lodge
Gero
United States - Palo Alto, California
START UP
1 Disclosed Funding Rounds $6,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases
We use AI to build clinically relevant disease phenotypes in real-world human data and
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 20 ,2023 | Series A | $6,000,000 |
VitaDAO
Melnichek Investments LTD
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
